durapatite has been researched along with Neurofibromatosis 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baglio, SR; de la Croix Ndong, J; Elefteriou, F; Granchi, D; Joubert, S; Makowski, AJ; Nyman, JS; Ono, K; Perrien, DS; Rios, JJ; Stevenson, DA; Uppuganti, S; Vignaux, G | 1 |
1 other study(ies) available for durapatite and Neurofibromatosis 1
Article | Year |
---|---|
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
Topics: Adolescent; Alkaline Phosphatase; Animals; Bone Development; Bone Diseases, Developmental; Bone Morphogenetic Protein 2; Calcification, Physiologic; Cells, Cultured; Child; Child, Preschool; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type II; Diphosphates; Disease Models, Animal; Durapatite; Humans; Immunoglobulin G; Infant; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Neurofibromatosis 1; Neurofibromin 1; Osteoblasts; Osteogenesis; Phosphate Transport Proteins; Phosphoric Diester Hydrolases; Pyrophosphatases; Recombinant Fusion Proteins; Sp7 Transcription Factor; Transcription Factors | 2014 |